Program
Beclomethasone
Also written as “Beclomethasone dipropionate”, “Beclometasone/Formoterol/Glycopyrrolate” and “beclomethasone”.
Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Rhinitis, Allergic, Seasonal · Rhinitis, Allergic, Perennial · Graft vs Host Disease, led by 7 companies.
Drug pageBeclomethasone: every studyMany companies study it; this page follows only the 44 they lead. All 85 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Chiesi Farmaceutici | 220 open or running | phase 4since Oct 28, 2020 | Sep 29, 2006 | none ahead |
| Teva Pharmaceutical Industriesits history only | 140 open or running | phase 4since Oct 28, 2003 | Oct 28, 2003 | none ahead |
| Soligenixits history only | 30 open or running | phase 3since Jun 19, 2009 | Jun 19, 2009 | none ahead |
| Adamis Pharmaceuticalsits history only | 20 open or running | phase 3since Feb 6, 2019 | Feb 6, 2019 | none ahead |
| Enteron Pharmaceuticalsits history only | 10 open or running | phase 3since Oct 4, 2005 | Oct 4, 2005 | none ahead |
| Lunan Pharmaceutical Groupits history only | 11 open or running | phase 3since Jul 21, 2026 | Jul 21, 2026 | Jun 2028phase 3 · NCT07768891 |
| SOFARits history only | 10 open or running | phase 1since Apr 26, 2021 | Apr 26, 2021 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Chiesi Farmaceutici only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 7 studies since Sep 29, 2006.
- Oct 11, 2011Phase 3 study in AsthmaNCT01475032 · 638 enrolled · Bulgaria, France, Germany and more
- Apr 23, 2012Phase 2 study in AsthmaNCT01584492 · 59 enrolled · Poland, Ukraine
- Aug 1, 20122 phase 3 studiesNCT01691677, NCT01658891
- Oct 4, 2012Phase 2 study in AsthmaNCT01803087 · 60 enrolled · Poland
- Aug 5, 2013Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT01917331 · 1,368 enrolled · Hungary
- Jan 9, 2014Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02040597 · 42 enrolled · Poland
- Apr 11, 2014Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02119234 · 36 enrolled · Poland
- May 21, 2014Phase 2 study in AsthmaNCT02148120 · 60 enrolled · United Kingdom
- Nov 15, 2016Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02975843 · 28 enrolled
- Aug 23, 2017Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT03268226 · 20 enrolled · Belgium, Hungary
- Oct 28, 2020Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT04671355
- Apr 27, 2021Phase 3 study in AsthmaNCT04886999 · 78 enrolled · Italy
- May 3, 2021Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT04876677 · 25 enrolled · Belgium, Hungary
- Mar 4, 2022Phase 3 study in AsthmaNCT05292586 · 1,377 enrolled · United States
TargetBeta
“Glucocorticoid receptor agonist”ChEMBL 37, by rule
Other programs on NR3C1
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Dexamethasonerule | AbbVie | phase 4 | 174 |
| Budesoniderule | AstraZeneca | phase 4 | 167 |
| fluticasone furoaterule | GlaxoSmithKline | phase 4 | 97 |
| Prednisonerule | Johnson & Johnson | phase 4 | 65 |
| Prednisolonerule | Sanofi | phase 4 | 34 |
| betamethasone dipropionaterule | LEO Pharma | phase 4 | 27 |
| Methylprednisolonerule | Pfizer | phase 4 | 23 |
| dexamethasone phosphaterule | eyegate-pharmaceuticals-inc | phase 4 | 21 |
| Betamethasonerule | LEO Pharma | phase 4 | 9 |
| Triamcinolonerule | research-insight-llc | phase 4 | 5 |
| relacorilantrule | Corcept Therapeutics | phase 3 | 22 |
| Triamcinolone Acetoniderule | clearside-biomedical-inc | phase 3 | 20 |
Studies
All 22 Chiesi Farmaceutici leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT05292586Asthma · United States | 3 | Completed | Jun 24, 2024 | 1,377 |
| NCT04876677Pulmonary Disease, Chronic Obstructive · Belgium, Hungary | 3 | Completed | Jan 3, 2022 | 25 |
| NCT04886999Asthma · Italy | 3 | Completed | Feb 1, 2023 | 78 |
| NCT04671355Pulmonary Disease, Chronic Obstructive | 4 | Withdrawn | Dec 22, 2021 | 0 |
| NCT03268226Pulmonary Disease, Chronic Obstructive · Belgium, Hungary | 3 | Completed | Jan 30, 2019 | 20 |
| NCT02975843Pulmonary Disease, Chronic Obstructive | 1 | Completed | Mar 21, 2017 | 28 |
| NCT02148120Asthma · United Kingdom | 2 | Completed | Oct 2014 | 60 |
| NCT02119234Pulmonary Disease, Chronic Obstructive · Poland | 1 | Completed | Feb 2015 | 36 |
| NCT02040597Pulmonary Disease, Chronic Obstructive · Poland | 1 | Completed | Apr 2015 | 42 |
| NCT01917331Pulmonary Disease, Chronic Obstructive · Hungary | 3 | Completed | Jan 14, 2016 | 1,368 |
| NCT01803087Asthma · Poland | 2 | Completed | Oct 2012 | 60 |
| NCT01658891Asthma in Children · Denmark | 3 | Withdrawn | Nov 2015 | 0 |
| NCT01691677Acute Rhinosinusitis · Italy | 3 | Completed | Jan 2014 | 166 |
| NCT01584492Asthma · Poland, Ukraine | 2 | Completed | Feb 2013 | 59 |
| NCT01475032Asthma · Bulgaria, France, Germany and more | 3 | Completed | Sep 2012 | 638 |
| NCT00861926Asthma · Bulgaria, Croatia, Czechia and more | 3 | Completed | Dec 7, 2010 | 1,714 |
| NCT00497523Asthma · Poland, Ukraine | 3 | Completed | 283 | |
| NCT00497237Asthma · Bulgaria, Italy, Ukraine | 3 | Completed | Mar 2010 | 382 |
| NCT00476268Asthma | 3 | Completed | Jan 2005 | 824 |
| NCT00413387Asthma · Austria, Poland, Ukraine | 3 | Completed | Aug 2005 | 219 |
| NCT00394368Asthma · Poland, Ukraine | 3 | Completed | 180 | |
| NCT00382889Asthma · Austria, Italy, Poland and more | 3 | Completed | 480 |
How it is read
Names in the registry
- “Beclomethasone dipropionate”, 6 entries
- “Beclometasone/Formoterol/Glycopyrrolate”, 2 entries
- “beclomethasone”, 2 entries
- “beclomethasone dipropionate plus formoterol fumarate combination”, 2 entries
- “Beclometasone dipropionate/Formoterol Fumarate/Glycopyrronium”, 2 entries
Conditions, from the studies’ own filings
- Asthma, 25 studies
- Pulmonary Disease, Chronic Obstructive, 7 studies
- Rhinitis, Allergic, Seasonal, 3 studies
- Rhinitis, Allergic, Perennial, 3 studies
- Graft vs Host Disease, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.